Breaking News Instant updates and real-time market news.

WU

Western Union

, STX

Seagate

$42.94

0.3 (0.70%)

09:40
01/08/18
01/08
09:40
01/08/18
09:40

Unusually active option classes on open January 8th

Unusual total active option classes on open include: Western Union (WU), Seagate (STX), Consumer Staples Sector SPDR (XLP), CVS Health (CVS), SPDR S&P Regional Banking (KRE), Snap Inc. (SNAP), Baidu (BIDU), Square (SQ), Russell Index (.RUT), and iShares Trust Barclays 20 Year Treasury Bond Fund (TLT).

WU

Western Union

STX

Seagate

$42.94

0.3 (0.70%)

XLP

Consumer Staples Sector SPDR

CVS

CVS Health

KRE

SPDR S&P Regional Banking ETF

SNAP

Snap

BIDU

Baidu

$245.14

-0.59 (-0.24%)

SQ

Square

RUT

Russell 2000 Index

TLT

iShares 20+ Year Treasury Bond Fund

$125.71

-0.36 (-0.29%)

  • 08

    Jan

  • 08

    Jan

  • 09

    Jan

  • 09

    Jan

  • 09

    Jan

  • 09

    Jan

  • 10

    Jan

  • 11

    Jan

  • 23

    Jan

  • 07

    Feb

WU Western Union

01/08/18
SUSQ
01/08/18
UPGRADE
Target $21
SUSQ
Neutral
Western Union upgraded to Neutral at Susquehanna
As previously reported, Susquehanna analyst James Friedman upgraded Western Union to Neutral from Negative. He believes the company may be working with Ripple Labs to potentially implement blockchain applications in remittance and sees that as a possible accelerator with business-to-business. Friedman raised his price target to $21 from $17 on Western Union shares.
12/14/17
12/14/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. CBS (CBS) initiated with an Overweight at Stephens. 2. Floor & Decor (FND) initiated with a Buy at Stifel. 3. Tronox (TROX) initiated with an Overweight at Barclays. 4. LivePerson (LPSN) initiated with a Buy at B. Riley FBR. 5. Western Union (WU) assumed with a Sell at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/08/18
SUSQ
01/08/18
UPGRADE
SUSQ
Neutral
Western Union upgraded to Neutral from Negative at Susquehanna
12/14/17
GSCO
12/14/17
INITIATION
Target $17
GSCO
Sell
Western Union assumed with a Sell at Goldman Sachs
Goldman Sachs analyst Lara Fourman assumed coverage of Western Union from Jim Schneider with a Sell rating and $17 price target. The analyst believes industry consolidation and competitive pricing pressure create risk to the company's earnings and share price.
STX Seagate
$42.94

0.3 (0.70%)

12/13/17
COWN
12/13/17
NO CHANGE
COWN
Outperform
JV settlement positive for both Western Digital and Seagate, says Cowen
Cowen analyst Karl Ackerman said Western Digital's (WDC) settlement agreement with Toshiba (TOSBF) is largely in line with his prior expectations and should lead to a better multiple for Western Digital shares since it removes one of investors' primary fears. The deal is also a positive for Seagate (STX), according to Ackerman, as it gives that company an opportunity to access NAND supply from Toshiba. The analyst, who maintains an Outperform rating on Western Digital, added that the company's updated guidance proves his prior view that Street estimates were "way too low."
10/24/17
RBCM
10/24/17
NO CHANGE
Target $40
RBCM
Sector Perform
Seagate price target raised to $40 from $35 at RBC Capital
RBC Capital analyst Amit Daryanani raised his price target on Seagate to $40 after Q1 results and guidance that implies improving end-demand trends. Daryanani maintains a Sector Perform rating on Seagate to reflect depressed free cash flows, lack of gross margin upside, and potential HDD revenue challenges as a result of ramp up in NAND supply.
01/05/18
KEYB
01/05/18
NO CHANGE
KEYB
KeyBanc calls memory checks mixed entering Q1
KeyBanc analyst Weston Twigg says his memory contacts maintain a mixed view on memory pricing this year, with DRAM likely up moderately and NAND down. The analyst continues to expect limited new DRAM supply until later this year, creating a tight supply/demand environment, and "substantial" new NAND capacity coming online in the first half of the year, driving lower pricing. He views DRAM strength as positive for Micron (MU), and NAND softness as a potential negative for Micron, Western Digital (WDC) and Seagate (STX).
11/14/17
WELS
11/14/17
INITIATION
Target $38
WELS
Market Perform
Seagate resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Aaron Rakers resumed coverage of Seagate Technology with a Market Perform rating and $38 price target.
XLP Consumer Staples Sector SPDR

CVS CVS Health

01/05/18
MSCO
01/05/18
UPGRADE
MSCO
Overweight
CVS Health upgraded to Overweight from Equal Weight at Morgan Stanley
01/05/18
01/05/18
UPGRADE
Target $88

Overweight
CVS Health upgraded to Overweight on Aetna deal potential at Morgan Stanley
As previously reported, Morgan Stanley analyst Ricky Goldwasser upgraded CVS Health (CVS) to Overweight from Equal Weight, contending that its planned acquisition of Aetna (AET) creates a path for accelerating EBIT growth from synergies and new Aetna membership. He also believes that in 2021 and beyond CVS has an opportunity to reshape access to healthcare by leveraging existing real estate to create local healthcare hubs, he tells investors. Goldwasser raised his price target on CVS shares to $88 from $81, adding that management's track record gives him confidence and that tax reform gives the company an "underappreciated war chest."
01/05/18
01/05/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CVS Health (CVS) upgraded to Overweight from Equal Weight at Morgan Stanley WITH analyst Ricky Goldwasser contending that its planned acquisition of Aetna (AET) creates a path for accelerating EBIT growth from synergies and new Aetna membership. 2. Eli Lilly (LLY) upgraded to Buy from Hold at Argus with analyst David Toung citing possible "blockbuster" launches of baricitinib and galcanezumab as well as a regulatory update on galcanezumab as potential 2018 catalysts. 3. Lowe's (LOW) was upgraded to Overweight from Equal Weight and Target (TGT) was upgraded to Equal Weight from Underweight at Barclays. 4. Foot Locker (FL) upgraded to Buy from Neutral at Buckingham with analyst Scott Krasik saying he believes key product assortments are improving and expects an inflection in comparables by the second quarter. 5. Jack in the Box (JACK) upgraded to Neutral from Sell at Goldman Sachs with analyst Karen Holthouse saying the company is a "strong beneficiary" of tax reform. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/05/18
RHCO
01/05/18
NO CHANGE
Target $90
RHCO
Buy
CVS Health price target raised to $90 from $85 at SunTrust
SunTrust analyst David MacDonald raised his price target on CVS Health to $90 after the company's FY18 outlook highlighted "solid underlying trends". MacDonalds says the company's operating income growth is in line with his estimate despite the "more pronounced headwind from the Anthem (ANTM) implementation and RxCrossroads divestiture", while remaining bullish on the pending Aetna (AET) deal and the benefits from the recent corporate tax rate changes. The analyst keeps his Buy rating on CVS Health.
KRE SPDR S&P Regional Banking ETF

SNAP Snap

01/08/18
SBSH
01/08/18
NO CHANGE
SBSH
Citi Q4 checks positive for Facebook and Twitter, mixed for Snap
Citi analyst Mark May says his early Q4 channel checks with two social marketing platforms, 4C Insights and Kenshoo, are positive for both Facebook (FB) and Twitter (TWTR) and mixed for Snap (SNAP). Jefferies this morning downgraded Snap to Hold from Buy. Citi's checks suggest that growth in spend across the Facebook platform remains strong and that the company's Q4 revenue could exceed consensus forecasts, May tells investors in a research note. 4C's data also suggests potential upside to Twitter (TWTR) revenue forecasts, and "potential disappointing revenue results" from Snap, May adds. While 4C just started supporting Snapchat in the second half of 2016, making its year-over-year unreliable, its data show client spend on the platform increased 22% sequentially Q4 as compared with 38% sequential growth in Q3, the analyst adds. He believes this suggests a potential Q4 revenue miss from Snap.
01/08/18
JEFF
01/08/18
DOWNGRADE
Target $15
JEFF
Hold
Snap downgraded to Hold from Buy at Jefferies
Jefferies analyst Brent Thill downgraded Snap to Hold with an unchanged price target of $15. The camera company closed Friday down 9c to $14.50. The analyst continues to have optimism around Snap's platform, but believes "fundamental execution needs to be shown" before he can be more positive on the name. Some negatives behind the app redesign could "lead to some turbulence in usage and adoption when rolled out," Thill tells investors in a research note. The analyst views the shares, currently trading at 18 times his 2018 revenue estimate, as fully valued.
01/05/18
SBSH
01/05/18
NO CHANGE
Target $1400
SBSH
Buy
Citi names Amazon top Internet pick for 2018, ups target to $1,400
Citi analyst Mark May remains bullish on the consumer Internet sector, especially over the near term. The analyst believes a "positive, tax reform fueled, business climate" should benefit the end-markets of the companies in the space. After outperformance in 2017, however, he recommends being more selective in 2018. Amazon.com (AMZN) moves up a spot to become his top-ranked pick for 2018. May sees the combination of greater than 30% sales growth, margin expansion and the current valuation as a "compelling mix." He raised his price target for Amazon shares to $1,400 from $1,250. May's most- to least-favored stocks under coverage, in order, are: Amazon, Expedia (EXPE), Facebook (FB), Priceline (PCLN), Alphabet (GOOGL), eBay (EBAY), Yelp (YELP), Twitter (TWTR), TripAdvisor (TRIP), Netflix (NFLX), GrubHub (GRUB), GoDaddy (GDDY), Despegar.com (DESP), trivago (TRVG), LendingClub (LC), Wayfair (W), Snap (SNAP), Zillow (ZG), Blue Apron (APRN) and Roku (ROKU), which he downgraded this morning to Sell.
01/04/18
01/04/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Roku (ROKU) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Benjamin Swinburne telling investors that he believes the market has overreacted following the company's stronger than expected third quarter results. 2. Snap (SNAP) downgraded to Underperform from Market Perform at Cowen with analyst John Blackledge saying Blackledge's Ad Buyer Survey results for Snap were mixed with modest share gains of Social/Video budgets in 2018/19 despite ranking ROI, data, and targeting ranking the lowest. 3. Western Digital (WDC) downgraded to Market Perform from Outperform at BMO Capital with analyst Tim Long saying the near-term fundamentals for the company remain healthy, but limited upside for growth in margins and revenue due to a more balanced supply-demand will keep the stock in a trading range. 4. Tableau (DATA) downgraded to Sector Weight from Overweight at KeyBanc with analyst Brent Bracelin saying the risk/reward is more balanced following the 64% rise in shares in 2017. 5. MasterCard (MA) downgraded to Outperform from Top Pick at RBC Capital with analyst Daniel Perlin saying the stock was a "monster" in 2017 with a 47% rise, and his investment thesis of accelerating top-line growth, tailwinds from higher oil prices and favorable FX, and global conversion to electronic payments remains in place. The analyst attributes the downgrade to "repositioning group headings" going into FY18. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BIDU Baidu
$245.14

-0.59 (-0.24%)

10/23/17
THCP
10/23/17
UPGRADE
THCP
Buy
Baidu upgraded to Buy from Hold at TH Data Capital
10/31/17
OPCO
10/31/17
NO CHANGE
Target $295
OPCO
Outperform
Baidu price target raised to $295 from $250 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Baidu to $295 from $250 after strong Q3 results and guidance for Q4 organic acceleration. The analyst reiterates an Outperform rating on the shares.
10/25/17
OTRG
10/25/17
UPGRADE
OTRG
Positive
Baidu upgraded to Positive from Mixed at OTR Global
01/08/18
WELS
01/08/18
NO CHANGE
Target $290
WELS
Outperform
Baidu price target raised to $290 from $275 at Wells Fargo
Wells Fargo analyst Ken Sena raised his price target for Baidu to $200 from $275 as he believes 2018 will benefit from many of the same underlying trends as in 2017, including the widening use of artificial intelligence, the increasing reliance on mobile, and the growing importance of Cloud. Nonetheless, the analyst sees some near-term earnings risk. He reiterates an Outperform rating on the shares.
SQ Square

01/04/18
01/04/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Square (SQ) initiated with a Buy at Buckingham. 2. Tyme Technologies (TYME) initiated with a Buy at Canaccord. 3. Visteon (VC) initiated with a Buy at Guggenheim. 4. Core-Mark (CORE) initiated with an Outperform at William Blair. 5. PJT Partners (PJT) initiated with a Neutral at Buckingham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/04/18
BUCK
01/04/18
INITIATION
Target $42
BUCK
Buy
Square initiated with a Buy at Buckingham
Buckingham analyst Chris Brendler initiated Square with a Buy and $42 price target saying it unique tech disruptor that is in the early stages of its global opportunity. Brendler said Square has a dominant SMB-focused payments franchise and high-margin software solutions scaling rapidly, which should continue to drive recent momentum.
12/19/17
MSCO
12/19/17
NO CHANGE
Target $40
MSCO
Equal Weight
Square price target raised to $40 from $26 at Morgan Stanley
Morgan Stanley analyst James Faucette noted that the firm's survey work has found high satisfaction with Square, though also a low propensity for small-and-medium businesses to switch from existing providers to Square. While Square's premium valuation assumes its strong momentum is sustainable, strong growth assumptions are achievable, he tells investors. However, multiple downside risks - including credit market volatility, a change in the pricing environment and trouble repeating its U.S. success internationally - could "catch the market offguard," Faucette tells investors. After changing his valuation methods, he raised his price target on Square to $40 from $26, though he keeps a Hold rating on the stock.
12/13/17
RHCO
12/13/17
NO CHANGE
Target $23
RHCO
Buy
Verifone multiple expansion supported by improving cash flows, says SunTrust
SunTrust analyst Andrew Jeffrey kept his Buy rating and a $23 price targat on Verifone (PAY) after its in-line Q4 results and "messy" FY18 guidance. Jeffrey says the company's offerings remain "relevant" across its merchant base despite the competition from Square (SQ), forecasting low-single digit organic revenue growth and better margins going forward. The analyst attributes the FY18 guidance miss to the Street not having adjusted its consensus view following the company's divestitures.
RUT Russell 2000 Index

TLT iShares 20+ Year Treasury Bond Fund
$125.71

-0.36 (-0.29%)

TODAY'S FREE FLY STORIES

INTC

Intel

$45.47

0.66 (1.47%)

12:45
01/22/18
01/22
12:45
01/22/18
12:45
Hot Stocks
Intel found root cause for Broadwell and Haswell platform issues »

Intel's Navin Shenoy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

QD

Qudian

$12.50

0.1 (0.81%)

12:45
01/22/18
01/22
12:45
01/22/18
12:45
Options
Qudian Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$44.82

0.34 (0.76%)

12:44
01/22/18
01/22
12:44
01/22/18
12:44
Hot Stocks
Breaking Hot Stocks news story on Intel »

Intel says made good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

INTC

Intel

$44.82

0.34 (0.76%)

12:43
01/22/18
01/22
12:43
01/22/18
12:43
Hot Stocks
Breaking Hot Stocks news story on Intel »

Intel recommends stopping…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

BAC

Bank of America

$31.76

0.04 (0.13%)

12:43
01/22/18
01/22
12:43
01/22/18
12:43
Periodicals
Bank of America eliminates remaining free-checking eBanking accounts, WSJ says »

Bank of America has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

MS

Morgan Stanley

$57.02

-0.44 (-0.77%)

12:38
01/22/18
01/22
12:38
01/22/18
12:38
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley »

Morgan Stanley says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$45.78

2.43 (5.61%)

12:35
01/22/18
01/22
12:35
01/22/18
12:35
Options
Avis Budget put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

$3.59

-0.01 (-0.28%)

12:30
01/22/18
01/22
12:30
01/22/18
12:30
Conference/Events
Akari Therapeutics management to meet with William Blair »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

12:25
01/22/18
01/22
12:25
01/22/18
12:25
Conference/Events
UBS REITs analyst holds an analyst/industry conference call »

REITs Analyst Yulico…

OMER

Omeros

$16.70

-0.02 (-0.12%)

12:24
01/22/18
01/22
12:24
01/22/18
12:24
Hot Stocks
Omeros off highs following cautious Twitter mention »

Shares of Omeros are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$281.54

1.125 (0.40%)

, SPX

S&P 500

12:21
01/22/18
01/22
12:21
01/22/18
12:21
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Schumer says deal reached…

SPY

SPDR S&P 500 ETF Trust

$281.54

1.125 (0.40%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$12.59

0.12 (0.96%)

12:20
01/22/18
01/22
12:20
01/22/18
12:20
Options
AMD attracts a bullish three-way spread before shares tick higher »

AMD attracts a bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

BG

Bunge

$80.40

2.84 (3.66%)

, ADM

Archer Daniels

$42.21

1.2505 (3.05%)

12:19
01/22/18
01/22
12:19
01/22/18
12:19
Recommendations
Bunge, Archer Daniels, Glencore analyst commentary  »

Credit Suisse says Archer…

BG

Bunge

$80.40

2.84 (3.66%)

ADM

Archer Daniels

$42.21

1.2505 (3.05%)

GLNCY

Glencore

$11.29

-0.02 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

$NSD

NASDAQ Market Internals

12:17
01/22/18
01/22
12:17
01/22/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
01/22/18
01/22
12:16
01/22/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

K

Kellogg

$66.78

0.16 (0.24%)

12:15
01/22/18
01/22
12:15
01/22/18
12:15
Options
Kellogg put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

12:10
01/22/18
01/22
12:10
01/22/18
12:10
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

BIVV

Bioverativ

$64.11

1.36 (2.17%)

, JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

12:08
01/22/18
01/22
12:08
01/22/18
12:08
General news
On The Fly: Top stock stories at midday »

Stocks opened mixed, with…

BIVV

Bioverativ

$64.11

1.36 (2.17%)

JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

VR

Validus

$67.50

20.775 (44.47%)

SNY

Sanofi

$43.23

-1.37 (-3.07%)

CELG

Celgene

$102.65

0.93 (0.91%)

AIG

AIG

$61.03

-0.525 (-0.85%)

IDRA

Idera Pharmaceuticals

$2.55

0.145 (6.03%)

BCRX

BioCryst

$5.59

-0.09 (-1.58%)

SANM

Sanmina

$35.45

0.5 (1.43%)

ARRY

Array BioPharma

$13.14

0.26 (2.02%)

FE

FirstEnergy

$33.23

3.83 (13.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 25

    Jan

  • 25

    Jan

  • 29

    Jan

  • 02

    Feb

  • 09

    Feb

  • 14

    Feb

  • 16

    Feb

  • 20

    Feb

  • 21

    Feb

  • 08

    Mar

  • 25

    Mar

  • 25

    Apr

  • 02

    May

  • 30

    Jun

  • 30

    Jun

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$281.18

0.765 (0.27%)

12:00
01/22/18
01/22
12:00
01/22/18
12:00
Periodicals
Senators have enough votes to end government shutdown, NBC reports 

Reference Link

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$281.18

0.765 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIVV

Bioverativ

$64.11

1.36 (2.17%)

, SNY

Sanofi

$43.22

-1.385 (-3.11%)

12:00
01/22/18
01/22
12:00
01/22/18
12:00
Hot Stocks
Hemophilia makers jump after Sanofi acquires peer Bioverativ for huge premium »

Shares of drug companies…

BIVV

Bioverativ

$64.11

1.36 (2.17%)

SNY

Sanofi

$43.22

-1.385 (-3.11%)

PFE

Pfizer

$36.88

-0.06 (-0.16%)

JNJ

Johnson & Johnson

$147.21

-0.15 (-0.10%)

ALNY

Alnylam

$124.83

0.84 (0.68%)

CBIO

Catalyst Biosciences

$19.49

0.86 (4.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Jan

  • 25

    Jan

  • 30

    Jan

  • 06

    Feb

  • 08

    Feb

  • 14

    Feb

  • 16

    Feb

  • 08

    Mar

  • 08

    Mar

  • 25

    Mar

  • 25

    Apr

  • 02

    May

IRIX

IRIDEX

$7.46

-0.11 (-1.45%)

12:00
01/22/18
01/22
12:00
01/22/18
12:00
Hot Stocks
BlueLine Partners reports 8.5% passive stake in IRIDEX »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OLN

Olin

$37.04

0.155 (0.42%)

12:00
01/22/18
01/22
12:00
01/22/18
12:00
Options
Opening activity in Olin calls »

Opening activity in Olin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

BK

BNY Mellon

$57.21

0.6 (1.06%)

11:58
01/22/18
01/22
11:58
01/22/18
11:58
Hot Stocks
BNY Mellon to launch FX prime brokerage service »

BNY Mellon announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

, CELG

Celgene

$102.65

0.93 (0.91%)

11:54
01/22/18
01/22
11:54
01/22/18
11:54
Downgrade
Juno Therapeutics, Celgene rating change  »

Juno Therapeutics…

JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

CELG

Celgene

$102.65

0.93 (0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

PM

Philip Morris

$109.21

0.29 (0.27%)

, XXII

22nd Century

$3.94

0.08 (2.07%)

11:52
01/22/18
01/22
11:52
01/22/18
11:52
Periodicals
FDA advisers to vote on clearance for Philip Morris iQOS device, Reuters says »

U.S. health advisers are…

PM

Philip Morris

$109.21

0.29 (0.27%)

XXII

22nd Century

$3.94

0.08 (2.07%)

BTI

British American Tobacco

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.